Geneva, March 20 -- International Clinical Trials Registry received information related to the study (CTRI/2026/02/104688) titled 'clinical trial to evaluate the Effect of Durva Ghrita Aschyotana, Ksheerbala Tail 101 Pratimarsha Nasya and Triphaladi compound in the Management of Computer Vision Syndrome' on Feb. 24.
Study Type: Interventional
Study Design:
Randomized, Parallel Group, Active Controlled Trial Method of generating randomization sequence:Computer generated randomization Method of allocation concealment:Alternation Blinding and masking:Open Label
Primary Sponsor: DR RICHA MOHAN
Condition:
Health Condition 1: H578- Other specified disorders of eye and adnexa
Recruitment Status: Not Recruiting
Phase: Phase 1
Date ...